Total Maci Implants, Kits, & Instruments was Vericel’s largest product and service line in fiscal 2025, bringing in $239.51M of $274.18M (87%).
| Product and Service | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|
| Total Maci Implants, Kits, & Instruments | $131.97M | $164.80M | $197.31M | $239.51M | |||
| Total Maci Implants & Kits | — | — | — | — | |||
| M A C I Implants & Kits | — | — | — | — | |||
| Epicel | $31.73M | $31.57M | $36.62M | $32.07M | |||
| Biopsy Kits & Instruments - Direct Bill | $2.09M | $2.09M | $2.10M | $2.61M | |||
| Biopsy Kits - Direct Bill | — | — | — | — | |||
| Biopsy Kits | — | — | — | — | |||
| Total | $165.79M | $198.46M | $236.03M | $274.18M |
Vericel brought in $274.18M from its three product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 16.2% from $236.03M in fiscal 2024. Total Maci Implants, Kits, & Instruments was the largest at $239.51M (87.4%), ahead of Epicel at $32.07M (11.7%) and Biopsy Kits & Instruments - Direct Bill at $2.61M (1.0%).
Compared with fiscal 2024, Total Maci Implants, Kits, & Instruments grew 21.4% to $239.51M, while Epicel fell 12.4% to $32.07M. From fiscal 2022 to 2025, combined revenue from these lines grew from $165.79M to $274.18M, a compound annual growth rate of 18.3%. Total Maci Implants, Kits, & Instruments' share of the total rose from 79.6% to 87.4%.
Vericel (VCEL) reports its revenue by product and service. In fiscal 2025, Total Maci Implants, Kits, & Instruments was its largest product and service line, bringing in $239.51M (87.4% of the total), followed by Epicel at $32.07M (11.7%).
Total Maci Implants, Kits, & Instruments was Vericel's largest product and service line in fiscal 2025, bringing in $239.51M, or 87.4% of the $274.18M total across its three product and service lines.
Total Maci Implants, Kits, & Instruments grew faster than Epicel in fiscal 2025, up 21.4% from $197.31M to $239.51M. Epicel fell 12.4% to $32.07M.
Every figure comes from Vericel's annual financial filings, as reported. Each line keeps the name Vericel gives it, and years follow its fiscal calendar.
Vericel's revenue by product and service goes back to fiscal 2019, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.